Evidence map›Paper›PMID 42348209›Full record

ArticleJAMA network open2026

Severity of Chronic Kidney Disease and Outcomes After Admission to the Intensive Care Unit.

Hajar El Wadia, Nickolas Beauregard, Samuel A Silver, Ron Wald, Ayub Akbari, Deena Fremont, Tim Ramsay, Gregory A Knoll, Edward G Clark, Gregory L Hundemer

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hajar El WadiaSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Nickolas BeauregardICES Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Samuel A SilverDepartment of Medicine, Division of Nephrology, Queen's University, Kingston, Ontario, Canada.
Ron WaldDepartment of Medicine, Division of Nephrology, St Michael's Hospital, Toronto, Ontario, Canada.
Ayub AkbariDepartment of Medicine, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Deena FremontDepartment of Medicine, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Tim RamsaySchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Gregory A KnollDepartment of Medicine, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Edward G ClarkDepartment of Medicine, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Gregory L HundemerSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Individuals with chronic kidney disease (CKD) are disproportionately admitted to the intensive care unit (ICU); however, the association between CKD severity and outcomes after ICU admission remains uncertain. Objective: To evaluate the association between CKD severity and health outcomes after ICU admission. Design, Setting, and Participants: This population-based cohort study was conducted from November 1, 2008, to February 28, 2021. Participants included 531 090 consecutive adult (≥18 years) residents of Ontario, Canada, admitted to an ICU during the study period who had a baseline outpatient serum creatinine measurement within 7 to 365 days prior to admission. Statistical analyses were conducted from July 23, 2025, to April 16, 2026. Exposure: CKD severity was classified according to the baseline outpatient estimated glomerular filtration rate (eGFR) Kidney Disease Improving Global Outcomes criteria. Main Outcomes and Measures: Mortality (ICU, hospital, and 90-day mortality) and kidney replacement therapy (KRT) requirement in the ICU and dependence at 90 days. Results: The study included 531 090 adults (mean [SD] age, 67 [15] years; 57% men) admitted to the ICU. One in 4 individuals had preexisting CKD: stage 3a CKD, eGFR 45 to 59 mL/min/1.73 m2 (12% of adults); stage 3b CKD, eGFR 30 to 44 mL/min/1.73 m2 (7% of adults); stage 4 CKD, eGFR 15 to 29 mL/min/1.73 m2 (3% of adults); non-dialysis-dependent stage 5 CKD, eGFR less than 15 mL/min/1.73 m2 (1% of adults); and undergoing maintenance dialysis (2% of adults). Compared with individuals without CKD, the severity of the disease among individuals with CKD was progressively associated with increased mortality risk up to non-dialysis-dependent stage 5 CKD. However, the risk of mortality was lower for individuals receiving maintenance dialysis (odds ratio [OR], 1.92 [95% CI, 1.82-2.04]) compared with those with non-dialysis-dependent stage 5 CKD (OR, 2.32 [95% CI, 2.14-2.52]). Risk for KRT initiation in the ICU increased with CKD severity relative to individuals without CKD: stage 3a (adjusted OR [AOR], 1.79 [95% CI, 1.68-1.90]), stage 3b (AOR, 3.02 [95% CI, 2.83-3.22]), stage 4 (AOR, 6.71 [95% CI, 6.23-7.22]), and non-dialysis-dependent stage 5 (AOR, 32.00 [95% CI, 29.07-35.22]). Among those who initiated KRT in the ICU and survived to 90 days, KRT dependence at day 90 increased progressively by CKD stage: no CKD, 7.2%; stage 3a, 14.2%; stage 3b, 22.5%; stage 4, 50.3%; and previously non-dialysis-dependent stage 5, 83.8%. Conclusions and Relevance: In this cohort study of consecutive adults admitted to the ICU, the presence and severity of CKD were associated with adverse health outcomes. These findings can inform risk prognostication, discussions about goals of care, resource allocation, and health policy initiatives for this large portion of the ICU population.

Indexed as

Intensive Care UnitsRenal Insufficiency, ChronicSeverity of Illness IndexAgedAged, 80 and overCohort StudiesFemaleGlomerular Filtration RateHospital MortalityHumansMaleMiddle AgedOntarioRenal Replacement Therapy

Identifiers

PMID42348209
PMCPMC13306308

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.